<DOC>
	<DOCNO>NCT02296723</DOCNO>
	<brief_summary>This study ass Valganciclovir Hydrochloride Tablets 450 mg Dr. Reddy 's Laboratories Limited , India ValcyteÂ® ( Valganciclovir HCl ) tablets 450 mg Genentech USA Inc. , Group Roche , South San Francisco healthy , adult , human subject Fed condition .</brief_summary>
	<brief_title>Bioavailability Study Valganciclovir Hydrochloride Tablets 450 mg Under Fed Condition</brief_title>
	<detailed_description>Open label , balance , randomize , two-treatment , two-period , two-sequence , cross , single dose , oral bioequivalence study Valganciclovir Hydrochloride Tablets 450 mg Fed condition .</detailed_description>
	<mesh_term>Valganciclovir</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<criteria>Healthy , adult , human volunteer 18 55 year age ( inclusive ) live around Ahmedabad city western part lndia Having Body Mass Index ( BMD 18.5 24.9 ( inclusive ) , calculate weight kg / height meter2 Not significant disease medical history clinically significant abnormal finding screen , medical history , physical examination , laboratory evaluation , L2 lead ECG Xray chest ( posteroanterior view ) record Able understand comply study procedure , opinion principal investigator Able give voluntary write informed consent participation trial In case Male subject : Willing practice acceptable barrier contraception method birth control entire duration study least 90 day last dose administration , case accidental pregnancy spouse willing abort pregnancy Or Surgically sterile undergone vasectomy In case female subject : Surgically sterilize ( Bilateral tubal ligation , bilateral oophorectomy , hysterectomy ) least 6 month prior study participation Or If child bear potential willing use suitable effective double barrier contraceptive method intra uterine device birth control abstinence entire study least 90 day last study drug administration case accidental pregnancy willing abort pregnancy Or Postmenopausal woman : Women postmenopausal least 1 year Follicle stimulate Hormone ( FSH ) level serum estradiol level ( without hormone replacement therapy ) within specify limit suggestive menopausal state , normal bilateral mammogram normal ultrasound abdomen pelvis And Pregnancy test must negative Known hypersensitivity idiosyncratic reaction Valganciclovir and/or ganciclovir excipients related drug History presence disease condition might compromise haemopoietic , renal , hepatic , endocrine , pulmonary , central nervous , cardiovascular , immunological , dermatological , gastrointestinal body system Ingestion medicine time within 14 day dose Period I In case subject selection discretion Principal Investigator . Any history presence asthma ( include aspirin induce asthma ) nasal polyp NSAID induce urticaria A recent history harmful use alcohol ( less 2 year ) , , e . alcohol consumption 14 standard drink per week men 7 standard drink per week woman ( A standard drink define 360 ml beer 150 ml wine 45 ml 40o/o distilled spirit , rum , whisky , brandy etc ) consumption alcohol alcoholic product within 48 hour prior receive study medicine Smokers , smoke 10 10 cigarettes/day inability abstain smoking study The presence clinically significant abnormal laboratory value screen Use recreational drug history drug addiction test positive prestudy drug scan History presence psychiatric disorder A history difficulty donate blood Donation blood ( 1 unit 350 mL ) receipt investigational medicinal product participation drug research study within period 90 day prior first dose study medication . Elimination halflife study drug take consideration inclusion subject study Note : In case blood loss &lt; 200 mL ; subject may dose 60 day blood donation last sample previous study A positive hepatitis screen include hepatitis B surface antigen HCV ( Hepatitis C Virus ) antibodies A positive test result HIV antibody An unusual diet , whatever reason ( e.g . lowsodium ) , four week prior receive study medicine . In case subject selection discretion Principal Investigator Consumption grape fruit grape fruit product within 48 hour prior dose . Nursing mother ( female )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>